Please login to the form below
New accounts: March - PR & Med Ed
The following tables list new pharmaceutical account wins notified to us by the winning agencies for the period December 2006 to February 2007 inclusive
The following tables list new pharmaceutical account wins notified to us by the winning agencies for the period December 2006 to February 2007 inclusive. Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may also be involved with some of the products listed in other ways, or in domestic, overseas or international markets.
|
|
|
|
|
|
Alliance Pharmaceuticals |
Labour induction website |
Obstetrics and gynaecology |
Hanson Zandi |
|
Baxter |
Pharmacy services |
Oncology |
Succinct Communications |
|
European Coalition of Positive People |
Integrated communications programme |
HIV/AIDS and Hepatitis C |
De Facto Communications |
|
Ferring International |
Euflexxa KOL development |
Orthopaedics |
Helen Lawn & Associates |
|
Ferring International |
Zomacton |
Endocrinology |
Helen Lawn & Associates |
|
Ferring Pharmaceuticals |
DesmoMelt |
Urology |
Helen Lawn & Associates |
|
Ferring Pharmaceuticals |
VSL 3 |
Gastroenterology |
Helen Lawn & Associates |
|
Healthspan |
Various |
Vitamins and supplements |
Spink Consumer Relations |
|
McNeil |
Immodium |
Diarrhoea |
Spink Consumer Relations |
|
Merck Pharmaceuticals |
Erbitux and Uftoral |
Colorectal cancer |
Red Door Communications |
|
MÛInlycke Healthcare |
Patient awareness initiative |
Infection control |
hsdcommunications |
|
Nelsons |
Rescue remedy |
Homeopathy |
Pegasus PR |
|
Novo Nordisk |
Vagifem |
Local oestrogen therapy |
Spink Consumer Relations |
|
Oxfordshire Bioscience Network |
Public-private partnership promotion |
Corporate |
De Facto Communications |
|
Pfizer |
New product |
Oncology |
Succinct Communications |
|
sanofi-aventis |
N/A |
VTE |
Medaxial |
Share
Related Hub content
Subscribe to our email news alerts
- Sanofi and Teva to collaborate on inflammatory bowel disease drug in deal worth $1.5bn
- Eli Lilly to acquire cancer specialist Point Biopharma in deal worth $1.4bn
- Regeneron and Intellia to develop additional gene editing therapies under expanded collaboration
- Novavax’s updated COVID-19 vaccine approved by FDA for emergency use
- Alzheimer’s Research UK awards Cardiff University researchers £387,000
- Actinic keratosis – a common skin condition that can lead to skin cancer
No results were found
PMHub
BOLDSCIENCE
We know what it takes to create brands, to start new conversations, to simply communicate complex science, to change lives…...
Latest intelligence
- Actinic keratosis – a common skin condition that can lead to skin cancer
- PMGroup talks to Volker Koscielny, Chief Medical Officer at Almirall, about the importance of remaining vigilant about skin checks, the prevalence of actinic keratosis in the UK and the steps...
- Man vs microbe: the fight against antimicrobial resistance
- How the emerging resistance to antibiotics is being exacerbated by a lack of research and development into new antibiotics...
- Is trust the key factor in digital HCP engagement? New whitepaper from Graphite Digital
- Based on research with HCPs in the UK, USA and France, Graphite Digital’s latest whitepaper sheds light on HCP perceptions of pharma-owned digital channels, and what organisations should be prioritising...
